Prevalence of suicidality in major depressive disorder: a systematic review and meta-analysis of comparative studies

H Cai, XM **e, Q Zhang, X Cui, JX Lin, K Sim… - Frontiers in …, 2021 - frontiersin.org
Background: Suicidality is common in major depressive disorder (MDD), but there has been
no systematic review published about all aspects of suicidality. This meta-analysis and …

Bipolar disorder and suicide: a review

JN Miller, DW Black - Current psychiatry reports, 2020 - Springer
Abstract Purpose of Review Bipolar disorder has the highest rate of suicide of all psychiatric
conditions and is approximately 20–30 times that of the general population. The purpose of …

Once-weekly semaglutide in adolescents with obesity

D Weghuber, T Barrett… - … England Journal of …, 2022 - Mass Medical Soc
Abstract Background A once-weekly, 2.4-mg dose of subcutaneous semaglutide, a glucagon-
like peptide-1 receptor agonist, is used to treat obesity in adults, but assessment of the drug …

Suicide ideation and attempts in a pediatric emergency department before and during COVID-19

RM Hill, K Rufino, S Kurian, J Saxena, K Saxena… - …, 2021 - publications.aap.org
OBJECTIVES: Elevated rates of mental health concerns have been identified during the
coronavirus disease 2019 (COVID-19) pandemic. In this study, we sought to evaluate …

MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled …

MC Mithoefer, AA Feduccia, L Jerome, A Mithoefer… - …, 2019 - Springer
Background Posttraumatic stress disorder is a prevalent mental health condition with
substantial impact on daily functioning that lacks sufficient treatment options. Here we …

Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: a randomized …

V Popova, EJ Daly, M Trivedi, K Cooper… - American Journal of …, 2019 - psychiatryonline.org
Objective: About one-third of patients with depression fail to achieve remission despite
treatment with multiple antidepressants. This study compared the efficacy and safety of …

Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: a randomized clinical trial

EJ Daly, MH Trivedi, A Janik, H Li, Y Zhang, X Li… - JAMA …, 2019 - jamanetwork.com
Importance Controlled studies have shown short-term efficacy of esketamine for treatment-
resistant depression (TRD), but long-term effects remain to be established. Objective To …

Efficacy and safety of fixed-dose esketamine nasal spray combined with a new oral antidepressant in treatment-resistant depression: results of a randomized, double …

M Fedgchin, M Trivedi, EJ Daly… - International Journal …, 2019 - academic.oup.com
Background About one-third of patients with depression fail to achieve remission despite
treatment with multiple antidepressants and are considered to have treatment-resistant …

Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study

N Zaki, L Chen, R Lane, T Doherty… - …, 2023 - nature.com
Patients with treatment-resistant depression (TRD) have higher rates of relapse and
pronounced decreases in daily functioning and health-related quality of life compared to …

Annual Research Review: Suicide among youth–epidemiology,(potential) etiology, and treatment

CB Cha, PJ Franz, E M. Guzmán… - Journal of Child …, 2018 - Wiley Online Library
Background Suicide is a leading cause of death and a complex clinical outcome. Here, we
summarize the current state of research pertaining to suicidal thoughts and behaviors in …